AI Article Synopsis

  • The study analyzed the SNP rs13181 in the ERCC2 gene to see if it's linked to the risk and prognosis of nasopharyngeal carcinoma (NPC) in Chinese patients.
  • Results indicated that while the rs13181 SNP was not associated with an increased risk for NPC, the GG and GT genotypes showed a worse tumor-free survival and overall survival compared to the TT genotype.
  • The findings suggest that while the SNP doesn't affect the risk of developing NPC, it could be a significant factor in predicting the prognosis for those who have it.

Article Abstract

Objective: We examined whether the single-nucleotide polymorphism (SNP) rs13181 in the gene encoding excision repair cross complementation group 2 (ERCC2) is associated with the risk and prognosis of nasopharyngeal carcinoma (NPC).

Methods: SNPs at rs13181 were genotyped in 439 NPC patients (NPC group) and 431 age- and gender-matched cancer-free controls (control group) from a region of China where NPC is endemic, and frequencies of GG, GT and TT genotypes were compared between the two groups in the case-control study. In a subset of 365 NPC cases, SNPs were examined for potential correlation with tumor-free survival time (TFS) and overall survival (OS).

Results: Relative to NPC risk with a TT genotype, NPC risk was similar with GT + GG genotypes (OR 1.052, 95% CI 0.656-1.688), after adjusting for gender, age, smoking history, and immunoglobin A against Epstein-Barr virus capsid antigen (EBV-VCA-IgA) status. Univariate analysis showed that the GG or GT genotype was associated with significantly worse TFS (p<0.001) and OS (p=0.010) than the TT genotype. Prognosis was significantly worse for men than for women (TFS, p=0.045; OS, p=0.031), for T3-T4 classification than for T1-T2 (TFS, p=0.009; OS, p=0.007), for N3 than for N0+N1+N2 (TFS, p<0.001; OS, p<0.001). Based on multivariate analysis, independent risk factors for poor TFS were GG or GT genotype (HR 2.629, 95% CI 1.625-4.254, p<0.001), T3-T4 classification (HR 2.146, 95% CI 1.244-3.701, p=0.006) and N3 (HR 2.527, 95% CI 1.574-4.059, p<0.001). GG or GT genotype (HR 2.217, 95% CI 1.283-3.832, p=0.004), gender (HR 1.989, 95% CI 1.046-3.785, p=0.036), T3-T4 (HR 2.431, 95% CI 1.306-4.526, p=0.005) and N3 (HR 2.693, 95% CI 1.637-4.432, p<0.001) were independent risk factors for poor OS.

Conclusion: The rs13181 SNP in ERCC2 does not appear to be associated with NPC risk, but it may serve as an independent prognostic factor for NPC recurrence and death.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982703PMC
http://dx.doi.org/10.2147/PGPM.S296215DOI Listing

Publication Analysis

Top Keywords

single-nucleotide polymorphism
8
risk prognosis
8
prognosis nasopharyngeal
8
nasopharyngeal carcinoma
8
npc risk
8
npc
6
association single-nucleotide
4
polymorphism rs13181
4
rs13181 ercc2
4
risk
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!